Concise review: Reactive astrocytes and stem cells in spinal cord injury: Good guys or bad guys?

Stem Cells

Volumn 33, Issue 4, 2015, Pages 1036-1041

  Lukovic, Dunja ^a   Stojkovic, Miodrag ^b,c   Moreno Manzano, Victoria ^d   Jendelova, Pavla ^e   Sykova, Eva ^e   Bhattacharya, Shomi S ^a   Erceg, Slaven ^a,e,f  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b Stem Cells Therapies in Neurodegenerative Diseases Lab Sevilla   (Spain)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^d Spebo Medical   (Serbia)

^e University of Kragujevac Medical Faculty   (Serbia)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Glia; Induced pluripotent stem cells; Neural differentiation; Neural stem cell; Spinal cord injury; Stem cell transplantation

Indexed keywords

AQUAPORIN 4; CHEMOKINE; CURCUMIN; EPHRIN; EXCITATORY AMINO ACID TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPID BINDING PROTEIN; NESTIN; PROTEIN S100B; PROTEOCHONDROITIN SULFATE; VESICULAR GLUTAMATE TRANSPORTER 1; VIMENTIN;

ASTROCYTE; BLOOD BRAIN BARRIER; CELL DAMAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; HUMAN; INFLAMMATION; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REMYELINIZATION; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; SPINAL CORD REGENERATION; STEM CELL; STEM CELL NICHE; TISSUE REGENERATION; ANIMAL; METABOLISM; NERVE REGENERATION; PHYSIOLOGY; PROCEDURES; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALIA;

ANIMALS; ASTROCYTES; HUMANS; NERVE REGENERATION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84925639531     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1959     Document Type: Review

References (57)

1. Ransom B, Behar T, Nedergaard M,. New roles for astrocytes (stars at last). Trends Neurosci 2003; 26: 520-522.
2. Sykova E, Nicholson C,. Diffusion in brain extracellular space. Physiol Rev 2008; 88: 1277-1340.
3. Eddleston M, Mucke L,. Molecular profile of reactive astrocytes-Implications for their role in neurologic disease. Neuroscience 1993; 54: 15-36.
4. Grossman SD, Rosenberg LJ, Wrathall JR,. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol 2001; 168: 273-282.
5. Kakulas BA,. The applied neuropathology of human spinal cord injury. Spinal Cord 1999; 37: 79-88.
6. Pekny M, Nilsson M,. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-434.
7. Tucker BA, Scheetz TE, Mullins RF, et al. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci USA 2011; 108: E569-576.
8. Silver J, Miller JH,. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-156.
9. Bradbury EJ, Carter LM,. Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2011; 84: 306-316.
10. Yick LW, Wu W, So KF, et al. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport 2000; 11: 1063-1067.
11. Fouad K, Schnell L, Bunge MB, et al. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 2005; 25: 1169-1178.
12. Pekny M, Wilhelmsson U, Bogestal YR, et al. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007; 82: 95-111.
13. Menet V, Prieto M, Privat A, et al. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci USA 2003; 100: 8999-9004.
14. Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004; 24: 2143-2155.
15. Hsu JY, McKeon R, Goussev S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 2006; 26: 9841-9850.
16. Okada S, Nakamura M, Katoh H, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12: 829-834.
17. Campbell G, Hutchins K, Winterbottom J, et al. Upregulation of activating transcription factor 3 (ATF3) by intrinsic CNS neurons regenerating axons into peripheral nerve grafts. Exp Neurol 2005; 192: 340-347.
18. Xu XM, Guenard V, Kleitman N, et al. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 1995; 134: 261-272.
19. Guest JD, Rao A, Olson L, et al. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol 1997; 148: 502-522.
20. Davies JE, Proschel C, Zhang N, et al. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 2008; 7: 24.
21. Alexanian AR, Svendsen CN, Crowe MJ, et al. Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Cytotherapy 2011; 13: 61-68.
22. Dietrich J, Noble M, Mayer-Proschel M,. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 2002; 40: 65-77.
23. Davies JE, Huang C, Proschel C, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5: 7.
24. Hill CE, Proschel C, Noble M, et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: Survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol 2004; 190: 289-310.
25. Bernstein JJ, Goldberg WJ,. Graft derived reafferentation of host spinal cord is not necessary for amelioration of lesion-induced deficits: Possible role of migrating grafted astrocytes. Brain Res Bull 1989; 22: 139-146.
26. Houle JD, Reier PJ,. Transplantation of fetal spinal cord tissue into the chronically injured adult rat spinal cord. J Comp Neurol 1988; 269: 535-547.
27. Weiss S, Dunne C, Hewson J, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996; 16: 7599-7609.
28. Hawryluk GW, Fehlings MG,. The center of the spinal cord may be central to its repair. Cell Stem Cell 2008; 3: 230-232.
29. Moreno-Manzano V, Rodriguez-Jimenez FJ, Garcia-Rosello M, et al. Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells 2009; 27: 733-743.
30. Barnabe-Heider F, Goritz C, Sabelstrom H, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 2010; 7: 470-482.
31. Enzmann GU, Benton RL, Talbott JF, et al. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 2006; 23: 479-495.
32. Cao Q, Benton RL, Whittemore SR,. Stem cell repair of central nervous system injury. J Neurosci Res 2002; 68: 501-510.
33. Cao Q, Xu XM, Devries WH, et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005; 25: 6947-6957.
34. Hasegawa K, Chang YW, Li H, et al. Embryonic radial glia bridge spinal cord lesions and promote functional recovery following spinal cord injury. Exp Neurol 2005; 193: 394-410.
35. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
36. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
37. Raya A, Rodriguez-Piza I, Guenechea G, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460: 53-59.
38. Erceg S, Ronaghi M, Stojkovic M,. Human embryonic stem cell differentiation toward regional specific neural precursors. Stem Cells 2009; 27: 78-87.
39. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694-4705.
40. Fujimoto Y, Abematsu M, Falk A, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012; 30: 1163-1173.
41. Romanyuk N, Amemori T, Turnovcova K, et al. Beneficial effect of human induced pluripotent stem cell-derived neural precursors in spinal cord injury repair. Cell Transplant 2014 [Epub ahead of print].
42. Tsuji O, Miura K, Fujiyoshi K, et al. Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells. Neurotherapeutics 2011; 8: 668-676.
43. Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 2010; 107: 12704-12709.
44. Nori S, Okada Y, Yasuda A, et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 2011; 108: 16825-16830.
45. Erceg S, Ronaghi M, Oria M, et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 2010; 28: 1541-1549.
46. Lukovic D, Valdes-Sanchez L, Sanchez-Vera I, et al. Brief report: Astrogliosis promotes functional recovery of completely transected spinal cord following transplantation of hESC-derived oligodendrocyte and motoneuron progenitors. Stem Cells 2014; 32: 594-599.
47. Tsuda M, Kohro Y, Yano T, et al. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 2011; 134: 1127-1139.
48. Riazifar H, Jia Y, Chen J, et al. Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells. Stem Cells Transl Med 2014; 3: 424-432.
49. Riesenberg AN, Le TT, Willardsen, MI, et al. Pax6 regulation of Math5 during mouse retinal neurogenesis. Genesis 2009; 47: 175-187.
50. Le TT, Wroblewski, E, Patel, S, et al. Math5 is required for both early retinal neuron differentiation and cell cycle progression. Dev Biol 2006; 295: 764-778.
51. Hamby ME, Sofroniew MV,. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 2010; 7: 494-506.
52. Hao HH, Wang L, Guo ZJ, et al. Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats. Neurosci Bull 2013; 29: 484-492.
53. Chen PS, Peng GS, Li G, et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 2006; 11: 1116-1125.
54. Lee JY, Kim HS, Choi HY, et al. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury. J Neurochem 2012; 121: 818-829.
55. Lin MS, Lee YH, Chiu WT, et al. Curcumin provides neuroprotection after spinal cord injury. J Surg Res 2011; 166: 280-289.
56. Laird MD, Sukumari-Ramesh S, Swift AE et al. Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? J Neurochem 2010; 113: 637-648.
57. Renault-Mihara F, Katoh H, Ikegami T, et al. Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. EMBO Mol Med 2011; 3: 682-696.